 | Short Interest in Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE) Decreases By 23.7%
americanbankingnews.com - April 18 at 1:56 AM |
 | Zynerba Pharmaceuticals Announces the Acceptance of Two Posters at the Society of Biological Psychiatry 2021 Virtual Meeting
finance.yahoo.com - April 15 at 8:38 AM |
| Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE) Receives Consensus Rating of "Buy" from Brokerages
americanbankingnews.com - April 9 at 8:44 AM |
| Zynerba Pharmaceuticals to Present at the Needham Virtual Healthcare Conference
finance.yahoo.com - April 6 at 7:51 AM |
| -$0.25 Earnings Per Share Expected for Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE) This Quarter
americanbankingnews.com - April 6 at 4:10 AM |
 | Zynerba (ZYNE) Alert: Shareholder Class Action...
benzinga.com - March 28 at 1:28 PM |
| Zynerba (ZYNE) Alert: Shareholder Class Action Survives Motion to Dismiss; Should Management be Held Accountable for Investors Losses? Contact Johnson Fistel
finance.yahoo.com - March 28 at 8:28 AM |
| Is Zynerba Pharmaceuticals (NASDAQ:ZYNE) In A Good Position To Invest In Growth?
finance.yahoo.com - March 12 at 1:13 PM |
| Zynerba Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results and Operational Highlights
finance.yahoo.com - March 10 at 8:26 AM |
 | Global Fibromyalgia Drugs Market Assessment 2021-2026 - Impact of COVID-19, Case Study Analysis, Key Opportunities and Major Players
marketwatch.com - March 5 at 2:35 PM |
|
| Zynerba Pharmaceuticals to Participate in the 33rd Annual ROTH Conference
finance.yahoo.com - March 4 at 12:40 PM |
| 4 Penny Stocks to Watch in March If You Like Biotech, Are They A Buy?
marketwatch.com - March 3 at 5:14 AM |
 | Marijuana as medicine: the other cannabinoid pharma players
seekingalpha.com - February 8 at 8:36 AM |
| GW Pharma Soars To Record High On Jazz's $7.2 Billion Takeover Deal
finance.yahoo.com - February 3 at 2:04 PM |
| Zynerba Pharmaceuticals to Present at Two January Virtual Investor Conferences
finance.yahoo.com - January 4 at 9:51 AM |
| ZYNE Dec 2020 7.500 put
sg.finance.yahoo.com - December 23 at 10:37 PM |
| Here's What We Think About Zynerba Pharmaceuticals' (NASDAQ:ZYNE) CEO Pay
finance.yahoo.com - December 23 at 12:36 PM |
 | Zynerba meets with FDA as development of its Fragile X syndrome program using Zygel advances
proactiveinvestors.com - December 19 at 11:41 PM |
 | Zynerba provides progress report on its potential Fragile X syndrome therapy
bizjournals.com - December 17 at 6:26 PM |
 | ZYNE : Single Trial To Be Conducted In Patients With Fragile X Syndrome To Confirm Positive Results
markets.businessinsider.com - December 17 at 8:23 AM |
| Zynerba Pharmaceuticals Provides Regulatory Update on Zygel™ in Fragile X Syndrome
finance.yahoo.com - December 17 at 8:23 AM |
| Shuman, Glenn & Stecker Investigates Zynerba Pharmaceuticals, Inc.
finance.yahoo.com - December 9 at 4:41 PM |
| The Law Offices of Frank R. Cruz Announces Investigation of Zynerba Pharmaceuticals (ZYNE) on Behalf of Investors
finance.yahoo.com - December 7 at 5:27 PM |
| The Law Offices of Frank R. Cruz Announces Investigation of Zynerba Pharmaceuticals (ZYNE) on Behalf of Investors
finance.yahoo.com - December 7 at 5:27 PM |
| Zynerba Pharmaceuticals Presents New Data in Two Posters at the 2020 Annual Meeting of the American Epilepsy Society (AES)
finance.yahoo.com - December 4 at 4:49 PM |
| Is Zynerba Pharmaceuticals (ZYNE) A Good Stock To Buy Now?
finance.yahoo.com - December 3 at 10:52 PM |
| Zynerba Pharmaceuticals EPS beats by $0.12
seekingalpha.com - November 9 at 8:24 AM |
| Zynerba Pharmaceuticals Reports Third Quarter 2020 Financial Results and Operational Highlights
finance.yahoo.com - November 9 at 8:24 AM |
|
| Zynerba Zygel Remains A Huge Part Of The Company's Pipeline Despite Setback
seekingalpha.com - October 29 at 7:04 AM |
| New data shows Zynerba's ZYN002 positive effect in autism study
seekingalpha.com - October 15 at 7:43 PM |
| Zynerba Pharmaceuticals Announces Oral Presentations at the Virtual American Academy of Child and Adolescent Psychiatry (AACAP) 2020 Annual Meeting
markets.businessinsider.com - October 8 at 9:38 AM |
| We're Keeping An Eye On Zynerba Pharmaceuticals' (NASDAQ:ZYNE) Cash Burn Rate
finance.yahoo.com - September 23 at 6:55 PM |
| Zynerba Pharmaceuticals (ZYNE) Jumps: Stock Rises 7.7%
finance.yahoo.com - September 18 at 12:34 PM |
| Zynerba Pharmaceuticals Receives Orphan Drug Designation for Cannabidiol for the Treatment of 22q11.2 Deletion Syndrome
finance.yahoo.com - September 17 at 3:30 PM |
| Zynerba Pharmaceuticals Provides Update on Recent Milestones
finance.yahoo.com - September 14 at 8:25 AM |
| Zynerba Pharmaceuticals to Present at Two Upcoming Virtual Investor Conferences
finance.yahoo.com - September 10 at 12:16 PM |
| Zynerba Pharmaceuticals Ireveals $77M on hand in 2Q results, says it can fund itself to 4Q 2021
proactiveinvestors.com - August 12 at 3:39 AM |
| Zynerba Pharmaceuticals EPS misses by $0.33
seekingalpha.com - August 10 at 7:32 AM |
| Zynerba Pharmaceuticals Reports Second Quarter 2020 Financial Results and Operational Highlights
benzinga.com - August 10 at 7:32 AM |
| Zynerba Pharmaceuticals Reports Second Quarter 2020 Financial Results and Operational Highlights
finance.yahoo.com - August 10 at 7:32 AM |
| Zynerba Pharmaceuticals to Present at the Virtual 40th Annual Canaccord Genuity Growth Conference
finance.yahoo.com - August 6 at 7:58 AM |
| Behavioral Therapy Market Size Forecast to Reach $187.4 Billion by 2025
www.marketwatch.com - July 30 at 8:06 PM |
| New Reasons For GW Pharmaceuticals To Ride High
seekingalpha.com - July 13 at 12:27 PM |
| Main Line pharma firm pushing ahead with new drug candidate despite setback
www.bizjournals.com - July 7 at 8:09 AM |
 | Zynerba's Zygel Fails in Phase III Fragile X Syndrome Study
www.nasdaq.com - July 1 at 2:21 PM |
| Zynerba's Zygel Fails in Phase III Fragile X Syndrome Study
finance.yahoo.com - July 1 at 2:21 PM |
 | BRIEF-Zynerba Pharmaceuticals Announces Top Line Results From Pivotal Connect-FX Trial Of Zygel
www.reuters.com - June 30 at 11:38 PM |
 | Zynerba Cannabinoid Investors Must Now Refocus on Treating Autism
www.msn.com - June 30 at 6:38 PM |
| Zynerba's Zygel flunks Fragile X study
seekingalpha.com - June 30 at 8:37 AM |
| Zynerba's cannabis-based drug for rare genetic disorder fails study
uk.reuters.com - June 30 at 8:37 AM |
